Orthopedic Research and Reviews
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Rationale, characteristics, and clinical performance of the OsteoSponge®: a novel allograft for treatment of osseous defects
(4144) Total Article Views
Authors: Miller LE, Jacofsky DJ, Kirker KR, Fitzpatrick KL, Juda GA, Block JE
Published Date April 2012
Volume 2012:4 Pages 9 - 17
|Received:||22 December 2011|
|Accepted:||02 March 2012|
|Published:||03 April 2012|
1Miller Scientific Consulting, Arden, NC, USA; 2Jon Block Group, San Francisco, CA, USA; 3CORE Institute, Phoenix, AZ, USA; 4Center for Biofilm Engineering, Bozeman, MT, USA; 5Department of Biological Structure, University of Washington, Seattle, WA, USA; 6Bacterin International, Belgrade, MT, USA
Abstract: A variety of bone grafts and bone graft substitutes, each with distinctly different characteristics, is available to the orthopedic surgeon for various reconstructive procedures. However, adequate reconstruction of osseous defects remains a therapeutic challenge. Each bone graft option has a unique set of benefits and risks that must be considered in relation to the particular pathology, and to patient characteristics and comorbidities, in order to achieve the best possible outcome. The OsteoSponge® allograft consists of 100% demineralized human cancellous bone, with no additional carrier materials. The OsteoSponge is compressible, allowing precise graft placement in most osseous defects; subsequent expansion completely fills the void. The material is prepared using methods that preserve native growth factors, thereby promoting cellular ingrowth, proliferation, and ultimately osteogenesis. Preliminary evidence suggests that the OsteoSponge matrix is safe and effective when used in surgical treatment of osseous defects. This article describes the rationale for, and characteristics of, the OsteoSponge, and summarizes the results from preclinical and human studies.
Keywords: allograft, bone graft, demineralized bone, osseous defect, OsteoSponge
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Other articles by Dr Jon Block
Readers of this article also read:
"You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.
- Local anesthetic failure associated with inflammation: verification of the acidosis mechanism and the hypothetic participation of inflammatory peroxynitrite
- Inflammatory mediators: Parallels between cancer biology and stem cell therapy
- Inflammatory mechanisms in the lung
- Effects of 4:1 carbohydrate/protein solution versus a carbohydrate-alone solution on IL-6, TNF-α, and cortisol during prolonged cycling in hot environmental conditions